Cargando…
Propensity of Patient-Derived iPSCs for Retinal Differentiation: Implications for Autologous Cell Replacement
Prior to use, newly generated induced pluripotent stem cells (iPSC) should be thoroughly validated. While excellent validation and release testing assays designed to evaluate potency, genetic integrity, and sterility exist, they do not have the ability to predict cell type-specific differentiation c...
Autores principales: | Cooke, Jessica A, Voigt, Andrew P, Collingwood, Michael A, Stone, Nicholas E, Whitmore, S Scott, DeLuca, Adam P, Burnight, Erin R, Anfinson, Kristin R, Vakulskas, Christopher A, Reutzel, Austin J, Daggett, Heather T, Andorf, Jeaneen L, Stone, Edwin M, Mullins, Robert F, Tucker, Budd A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267581/ https://www.ncbi.nlm.nih.gov/pubmed/37221451 http://dx.doi.org/10.1093/stcltm/szad028 |
Ejemplares similares
-
Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9
por: Bohrer, Laura R., et al.
Publicado: (2019) -
Microfluidic processing of stem cells for autologous cell replacement
por: Stone, Nicholas E., et al.
Publicado: (2021) -
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness
por: Wiley, Luke A., et al.
Publicado: (2016) -
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
por: Zhang, Y, et al.
Publicado: (2011) -
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells
por: Zhao, N, et al.
Publicado: (2011)